Pharmaceutical interventions in pediatric oncology: integrative literature review
DOI:
https://doi.org/10.33448/rsd-v12i3.40602Keywords:
Clinical pharmacy service; Clinical pharmacists; Oncology; Pediatrics.Abstract
This integrative literature review aimed to gather and analyze evidence on pharmaceutical interventions (PI) in pediatric oncology and their acceptance by the multidisciplinary team of antineoplastic therapy. The searches were carried out in PubMed, EMBASE and in the Regional Portal of the Virtual Health Library (BVS), in addition, complementary manual searches were carried out in Google Scholar. We included 24 studies without language and publication date restrictions. The most frequent PI were: dose/dosage adjustment, pharmaceutical guidance, need for additional treatment, adjustment of infusion and dilution rate, most appropriate therapeutic alternative, evaluation of treatment effectiveness, drug suspension, medication conciliation and therapy change. The anticancer drugs most involved in PI were etoposide and vincristine and for supportive treatment: ondansetron and sulfamethoxazole+trimethoprim. The acceptability of the PI ranged from 81 to 100%. The results evidence the role of the clinical pharmacist in the prevention, identification and resolution of drug-related problems in pediatric oncology.
References
Abdelhadi,O., & Tuffaha, (2010). Pediatric oncology clinical pharmacy interventions in a omprehensive Cancer Center. Journal of Oncology Pharmacy Practice, 16 (2), p. 20.
Agnol, R. D., Dos Santos, M. T., Michalowski, M. B., & Einsfeld, L. (2021). Pharmacists’ interventions on 2 years of drug monitoring in an oncology pediatric inpatient ward. Journal of Oncology Pharmacy Practice, 28, (8), p. 1754-1762.
Ali, K., Al-Quteimat, O., Naseem, R., Malhi, S. M., Wajdi, M., Jahan, N., & Shamsi, T. S. (2021). Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology–oncology and transplant clinic: Assessment and significance. Journal of Oncology Pharmacy Practice, 27(4), 815-820.
Anacleto, T. A., Rosa, M. B., Neiva, H. M., & Martins, M. A. P. (2010). Erros de medicação. Pharm bras, 74(1), 1-23.
Bauters, T., Verlooy, J., De Porre, J., De Moerloose, B., Benoit, Y., & Robays, H. (2009). Clinical pharmacy activities at a Pediatric Hemato-Oncology Unit. In Annual conference of the international society of paediatric oncology, São Paulo, SP.
Bradley, K. Z. (2018). Implementation of pharmacist led medication discharge teaching follow-up for pediatric leukemia patients in the outpatient setting. In Annual Meeting for the Hematology/Oncology Pharmacy Association, Denver, Colorado, EUA.
Brateibach, V., de Domenico, E. B. L., Berlezi, E. M., Loro, M. M., Rosanelli, C. D. L. S. P., Gomes, J. S., & Kolankiewicz, A. C. B. (2013). Sintomas de pacientes em tratamento oncológico. Ciência & Saúde, 6(2), 102-109.
Cicogna, E. D. C., Nascimento, L. C., & Lima, R. A. G. D. (2010). Children and adolescents with cancer: experiences with chemotherapy. Revista latino-americana de enfermagem, 18(5), 864-872.
Conselho Federal de Farmácia (2016). Tipos de serviços farmacêuticos e seus conceitos. Serviços farmacêuticos diretamente destinados ao paciente, à família e à comunidade: contextualização e arcabouço conceitual (p. 71-89). Brasília, DF: Conselho Federal de Farmácia.
Defoe, K. D., Jupp, J., & Leslie, T. (2019). Integration of clinical pharmacists into an ambulatory, pediatric hematology/oncology/transplant clinic. Journal of Oncology Pharmacy Practice, 25(3), 607-612.
Evans, W. E., Petros, W. P., Relling, M. V., Crom, W. R., Madden, T., Rodman, J. H., & Sunderland, M. (1989). Clinical pharmacology of cancer chemotherapy in children. Pediatric Clinics of North America, 36(5), 1199-1230.
Falzon, S. (2018). Development of a pharmaceutical care model within paediatric oncology. Jounal of the American College of clinical phamacy, 1(1), 246.
Fentie, A., & Hailu, D. (2020). Clinical pharmacy services in a pediatric hematology/oncology ward of tikur anbessa specialized Hospital, Addis Ababa, Ethiopia: prospective audit and feedback. Pediatr Blood Cancer 67(4), 138.
Gandhi, T. K., Bartel, S. B., Shulman, L. N., Verrier, D., Burdick, E., Cleary, A., & Bates, D. W. (2005). Medication safety in the ambulatory chemotherapy setting. Cancer: Interdisciplinary International Journal of the American Cancer Society, 104(11), 2477-2483.
Gebi, M., Titze, M. I., & Hockel, M. (2018). Evaluation of medication errors in a pediatric oncology war. In European Journal of Oncology Pharmacy 1, (2), p. 31.
Hamel, C., Tortolano, L., Bermudez, E., Desmaris, R., Klein, S., Slimano, F., & Lemare, F. (2018). Computerized pediatric oncology prescriptions review by pharmacist: a descriptive analysis and associated risk factors. Pediatric Blood & Cancer, 65(4), 26897.
Him, K., Wong, A. C. N., Chan, G. C. M., & Lee, B. C. S. (2017). Clinical pharmacy service in children cancer centre and bone marrow transplant unit at a local hospital in Hong Kong. Journal of oncology pharmacy practice, 23(4), p. 13.
Hong, S., Lee, J. H., Chun, E. K., Kim, K. I., Kim, J. W., Kim, S. H., & Kim, J. H. (2020). Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First‐Line Palliative Chemotherapy. The oncologist, 25(3), 502-511.
Instituto Nacional do Câncer (2020). INCA lança estimativas de casos novos de câncer para o triênio 2020-2022. https://www.inca.gov.br/imprensa/inca-lanca-estimativas-de-casos-novos-de-cancer-para-o-trienio2020.2022#:~:text=De%20acordo%20com%20a%20publica%C3%A7%C3%A3o,4.150%20para%.
Instituto Nacional do Câncer (2022). Câncer infantojuvenil .https://www.gov.br/inca/ptbr/assuntos/cancer/tipos/infantojuvenil#:~:text=Os%20tumores%20mais%20frequentes%20na,os%20linfomas%20(sistema%20linf%C3%A1tico).
Ivama, A. M., Noblat, L., Castro, M. S. D., Jaramillo, N. M., & Rech, N. (2002). Consenso brasileiro de atenção farmacêutica: proposta. In Consenso brasileiro de atenção farmacêutica: proposta (p. 24-24).
Kim, H. J., Lee, S., Lee, Y. J., Kim, S., Jo, Y. H., Cho, Y. S., & Lee, J. Y. (2021). Clinical and Economic Impact of Pharmacists’ Intervention on Care of Pediatric Hematology and Oncology Patients. Journal of Oncology Pharmacy Practice, 0 (0), 1-7.
Lam, M. S. (2011). Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 31(2), 164-192.
Magalhães, T. C., Ferrari, C. K. B., & David, F. L. (2013). Aspectos críticos da prescrição de medicamentos em pediatria. Evidência, 13(1), 15-8.
Mendes, K. D. S., Silveira, R. C. D. C. P., & Galvão, C. M. (2008). Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & contexto-enfermagem, 17, 758-764.
Morales, J., Jesus, M. C. H., Emma, V. C., Villaroel, C. M., & Marambio, F. S. (2015). Outcomes of a clinical pharmacy service in the checking and validation of chemotherapy prescriptions to prevent medication errors: a 21-month study from a Chilean pediatric hospital. In Pharmacotherapy, 35, (11), 199.
Penha, N. S., Silva, M. V., & Barros, M. A. (2020). Medication reconciliation in pediatric patients with cancer at Brazilian public hospital. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 11(3), 337-337.
Pinho, M. S., Abreu, P. A., & Nogueira, T. A. (2016). Atenção farmacêutica a pacientes oncológicos: uma revisão integrativa da literatura. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 7(1), 33-39.
Ramadaniati, H. U., Lee, Y. P., & Hughes, J. D. (2014). The difference in pharmacists’ interventions across the diverse settings in a children’s hospital. PLoS One, 9(10), 1-6.
Ramadaniati, H. U., Lee, Y. P., Hughes, J. D., & Emmerton, L. (2016). Pharmacists’ interventions in a paediatric haematology-oncology pharmacy: do they matter to minimise medication misadventure?. Indonesian Journal of Clinical Pharmacy Volume, 5(1), 1-10.
Resolução nº 220 de setembro de 2004. Dispõe sobre o Regulamento Técnico que fixa os requisitos mínimos exigidos para funcionamento dos Serviços de Terapia Antineoplásica.
Ribeiro, V. F., Sapucaia, K. C. G., Aragão, L. A. O., Bispo, I. C. D. S., Oliveira, V. F., & Alves, B. L. (2015). Realização de intervenções farmacêuticas por meio de uma experiência em farmácia clínica. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 6(4).
Rinke, M. L., Shore, A. D., Morlock, L., Hicks, R. W., & Miller, M. R. (2007). Characteristics of pediatric chemotherapy medication errors in a national error reporting database. Cancer, 110(1), 186-195.
Silva, F. M., Jesus Henriquez, C., Romina Escobar, R., & Jorge Morales, V. (2015). Implementation of a pharmaceutical care service in the outpatient pediatric oncology clinic.Pharmacotherapy 35, (11), 253.
Spager, V., Pernille, R., Madsen, M., Megaard, P., & Mathiasen, R. (2015). Review of prescribed medication and close cooperation with pharmacist leads to reduction of medication errors in a paediatric oncology department. In Pediatric blood & cancer 62, 336.
Taylor, T. L., Dupuis, L. L., Nicksy, D., & Girvan, C. (1999). Clinical pharmacy services in a pediatric hematology/oncology clinic: a description and assessment. Canadian Journal of Hospital Pharmacy, 52(1), 18-23.
Tuffaha, H. W., & Koopmans, S. M. (2012). Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center. Journal of Oncology Pharmacy Practice, 18(2), 180-185.
Tuffaha, H. W., Abdelhadi, O., & Omar, S. A. (2012). Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center. International journal of clinical pharmacy, 34(1), 27-31.
World Health Organization (2022). Câncer. https://www.who.int/news-room/fact-sheets/detail/cancer.
Yismaw, M. B., Adam, H., & Engidawork, E. (2020). Identification and resolution of drug-related problems among childhood cancer patients in Ethiopia. Journal of oncology, 1-9.
Zimmer, J., Niemann, D., Seltmann, K., Fischer, L., Christiansen, H., Frontini, R., & Bertsche, T. (2016). Managing of oral medicines in paediatric oncology: can a handbook and a pharmaceutical counselling intervention for patients and their parents prevent knowledge deficits? A pilot study. European Journal of Hospital Pharmacy, 23(2), 100-105.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Isla Millena Batista dos Santos; Kaio Vinícius Freitas de Andrade
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
